SCHEMBL27623743

SCHEMBL27623743

CC1CCC(N)(CC(=O)O)C1C

nearest known ligand 0.41

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.41
GRM2 Q14416 4/20 0.33
GRM5 P41594 1/20 0.33
GRM1 Q13255 1/20 0.33
USP2 O75604 1/20 0.33
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
TSHR P16473 1/20 0.33
BLM P54132 1/20 0.33
CACNA2D1 P54289 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
POLB P06746 1/20 0.33
CYP2C19 P33261 1/20 0.31
GRM6 O15303 2/20 0.30
GRM3 Q14832 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27468264 0.98 CYP1A2 (0.40) CYP1A2GRM2GRM5GRM1USP2
SCHEMBL28750382 0.89 CYP1A2 (0.46) CYP1A2USP2ALDH1A1LMNATSHR
Hydrochloric Acid SCHEMBL27548751 0.87 CYP1A2 (0.45) CYP1A2USP2ALDH1A1LMNATSHR
SCHEMBL27545369 0.80 CYP1A2 (0.39) CYP1A2GRM2GRM5GRM1USP2
Hydrochloric Acid SCHEMBL27468730 0.78 CYP1A2 (0.42) CYP1A2GRM2GRM5GRM1USP2
SCHEMBL5438031 0.74 CYP1A2 (0.39) CYP1A2USP2ALDH1A1LMNATSHR
SCHEMBL5437213 0.74 CYP1A2 (0.39) CYP1A2USP2ALDH1A1LMNATSHR
SCHEMBL6805426 0.74 CYP1A2 (0.39) CYP1A2USP2ALDH1A1LMNATSHR
SCHEMBL14459031 0.74 CYP1A2 (0.39) CYP1A2USP2ALDH1A1LMNATSHR
SCHEMBL5437305 0.74 CYP1A2 (0.39) CYP1A2USP2ALDH1A1LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101283995-A Different pharmaceutical uses alpha2delta ligands WARNER LAMBERT CO (US) 2008-10-15 CN disclosed
CN-1878546-A Combination comprising an alpha-2 delta ligand and an SSRI and/or SNRI for the treatment of depression and anxiety WARNER LAMBERT CO (US) 2006-12-13 CN disclosed
CN-1726015-A Alpha 2 delta ligands for different pharmaceutical uses WARNER LAMBERT CO (US) 2006-01-25 CN disclosed
CN-1678298-A Use of an alpha2delta ligand such as gabapentin or pregabalin for treating ttention deficit hyperactivity disorder WARNER LAMBERT CO (US) 2005-10-05 CN disclosed
CN-1625393-A Alpha 2 delta ligands to treat tinnitus WARNER LAMBERT CO (US) 2005-06-08 CN disclosed